Here are four takeaways:
1. The presentations included:
- One year results of an international multi-center study of EndoStim therapy for refractory GERD
- Interim results from EndoStim’s international patient registry
- Four year outcomes of EndoStim therapy
- Effect of EndoStim on reflux mechanisms in GERD patients
2. Also presented was an additional independent study examining under-diagnosed and inadequately-treated GERD patients, titled “Inadequate Symptom Control on Long-Term PPI Therapy in GERD – Fact or Fiction?”.
3. EndoStim developed a minimally-invasive implant that restores normal esophageal function through neurostimulation.
4. The United States has not approved the EndoStim system.
More articles on GI & endoscopy:
Dr. Kenneth Chang performs 1st TIF procedure using new EsophyX Z device: 6 things to know
Double reprocessing duodenoscopes reduces infection transmission risk: 4 insights from new research
Early cancer detection found with free colonoscopies — 5 points
